222 related articles for article (PubMed ID: 15582530)
1. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
[TBL] [Abstract][Full Text] [Related]
2. Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.
Arévalo-Herrera M; Roggero MA; Gonzalez JM; Vergara J; Corradin G; López JA; Herrera S
Ann Trop Med Parasitol; 1998 Jul; 92(5):539-51. PubMed ID: 9797827
[TBL] [Abstract][Full Text] [Related]
3. Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys.
López JA; González JM; Kettner A; Arévalo-Herrera M; Herrera S; Corradin G; Roggero MA
Ann Trop Med Parasitol; 1997 Apr; 91(3):253-65. PubMed ID: 9229019
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
[TBL] [Abstract][Full Text] [Related]
5. The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.
Rojas Caraballo J; Delgado G; Rodriguez R; Patarroyo MA
Vaccine; 2007 May; 25(18):3713-21. PubMed ID: 17240494
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.
Giraldo MA; Arevalo-Pinzon G; Rojas-Caraballo J; Mongui A; Rodriguez R; Patarroyo MA
Vaccine; 2009 Dec; 28(1):7-13. PubMed ID: 19782110
[TBL] [Abstract][Full Text] [Related]
7. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
[TBL] [Abstract][Full Text] [Related]
8. T cell epitopes of the circumsporozoite protein of Plasmodium vivax. Recognition by lymphocytes of a sporozoite-immunized chimpanzee.
Nardin E; Clavijo P; Mons B; van Belkum A; Ponnudurai T; Nussenzweig RS
J Immunol; 1991 Mar; 146(5):1674-8. PubMed ID: 1704402
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax.
Millet P; Chizzolini C; Wirtz RA; Bathurst I; Broderson JR; Campbell GH; Collins WE
Eur J Immunol; 1992 Feb; 22(2):519-24. PubMed ID: 1371470
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
Franke ED; Corradin G; Hoffman SL
J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
Das P; Grewal JS; Mahajan B; Chauhan VS
Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
[TBL] [Abstract][Full Text] [Related]
12. Inducing a cell-mediated immune response against peptides of the Plasmodium vivax circumsporozoite protein.
Thomas BE; Sridevi K; Chopra N; Haq W; Rao DN
Ann Trop Med Parasitol; 2001 Sep; 95(6):573-86. PubMed ID: 11672463
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to the repeat epitope of the circumsporozoite protein of Plasmodium vivax in San Luis Potosi, Mexico.
Mota J; Coreño O; Cochrane AH; Ramos C
Arch Med Res; 1996; 27(2):233-6. PubMed ID: 8696070
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the humoral response to repeat and non-repeat sequences of the circumsporozoite protein of Plasmodium vivax using novel adjuvant and delivery systems.
Thomas BE; Manocha M; Haq W; Adak T; Pillai CR; Rao DN
Ann Trop Med Parasitol; 2001 Jul; 95(5):451-72. PubMed ID: 11487368
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
16. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
[TBL] [Abstract][Full Text] [Related]
17. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
18. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
[TBL] [Abstract][Full Text] [Related]
19. Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein.
Herrera S; Escobar P; de Plata C; Avila GI; Corradin G; Herrera MA
J Immunol; 1992 Jun; 148(12):3986-90. PubMed ID: 1376347
[TBL] [Abstract][Full Text] [Related]
20. Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine.
Bermúdez A; Vanegas M; Patarroyo ME
Vaccine; 2008 Dec; 26(52):6908-18. PubMed ID: 18930095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
